Deciphering the Latest Clinical Data for EGFR-Mutated Advanced NSCLC: Unveiling Expert Insights

Keeping Current
21/10/2024 32 min
Deciphering the Latest Clinical Data for EGFR-Mutated Advanced NSCLC: Unveiling Expert Insights

Listen "Deciphering the Latest Clinical Data for EGFR-Mutated Advanced NSCLC: Unveiling Expert Insights"

Descargar episodio Ver en sitio original

Episode Synopsis

Therapeutic options for frontline management of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) are rapidly evolving. Are you up to date on the evidence?    Credit available for this activity expires: 09/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001657?ecd=bdc_podcast_libsyn_mscpedu

More episodes of the podcast Keeping Current

Patient Case Challenge: How Would You Manage This Patient With MASH? 31/12/2025
Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies 24/12/2025
Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences 19/12/2025
Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy 18/12/2025
How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies 12/12/2025
Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies 10/12/2025
Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care 09/12/2025
How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer? 05/12/2025
Staying Ahead of the First Event: Evaluating the Evidence for Early LDL-C Lowering 04/12/2025
Optimizing Outcomes for Patients With IgAN: Novel B-Cell Targeted Therapies and the Changing Treatment Paradigm 02/12/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA